HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nina Singh Selected Research

Valganciclovir

1/2022Unexpected Cytomegalovirus (CMV) Replication Kinetics in CMV Donor-Seropositive, Recipient-Seronegative Liver Transplant Recipients Receiving Preemptive Antiviral Therapy.
11/2021Association of HHV-6 With Outcomes in CMV-seronegative Liver Transplant Recipients With CMV-seropositive Donors Receiving Preemptive Antiviral Therapy.
1/2020Effect of Preemptive Therapy vs Antiviral Prophylaxis on Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors: A Randomized Clinical Trial.
8/2010Preemptive therapy for cytomegalovirus based on real-time measurement of viral load in liver transplant recipients.
2/2008Valganciclovir as preemptive therapy for cytomegalovirus in cytomegalovirus-seronegative liver transplant recipients of cytomegalovirus-seropositive donor allografts.
1/2005Efficacy of valganciclovir administered as preemptive therapy for cytomegalovirus disease in liver transplant recipients: impact on viral load and late-onset cytomegalovirus disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nina Singh Research Topics

Disease

50Infections
01/2021 - 08/2000
21Cryptococcosis
10/2015 - 05/2004
16Aspergillosis
11/2018 - 11/2002
9Viremia
01/2022 - 04/2002
9Mycoses (Diseases, Fungus)
11/2018 - 03/2003
9Fungemia
04/2017 - 10/2005
8Opportunistic Infections (Opportunistic Infection)
01/2020 - 01/2005
8Renal Insufficiency (Renal Failure)
02/2015 - 02/2006
6Invasive Fungal Infections
12/2015 - 01/2002
6Immune Reconstitution Inflammatory Syndrome
07/2015 - 06/2007
5Cytomegalovirus Infections (Inclusion Disease)
01/2020 - 07/2002
5Sepsis (Septicemia)
01/2017 - 01/2009
4Late Onset Disorders
01/2019 - 10/2008
4Fibrosis (Cirrhosis)
07/2015 - 04/2002
4Invasive Candidiasis
03/2010 - 01/2002
3Virus Diseases (Viral Diseases)
12/2017 - 07/2002
3Neoplasms (Cancer)
01/2017 - 10/2007
3Tuberculosis (Tuberculoses)
11/2016 - 09/2002
3Bacterial Infections (Bacterial Infection)
11/2012 - 05/2005
3End Stage Liver Disease
11/2012 - 02/2010
3Zygomycosis (Phycomycosis)
09/2009 - 09/2008
3Bacteremia
12/2007 - 07/2004
2Critical Illness (Critically Ill)
11/2021 - 01/2017
2Neutropenia
01/2020 - 01/2020
2Mucormycosis
11/2018 - 04/2011
2Central Nervous System Diseases (CNS Diseases)
01/2015 - 01/2010
2Hepatocellular Carcinoma (Hepatoma)
09/2013 - 12/2007
2Inflammation (Inflammations)
02/2011 - 10/2010
2Atherosclerotic Plaque (Atheroma)
10/2010 - 05/2010
2Iron Overload
09/2008 - 12/2007
2Hepatitis
05/2005 - 04/2002
1Congenital Heart Defects (Congenital Heart Defect)
03/2021
1COVID-19
10/2020
1Epstein-Barr Virus Infections
12/2017
1Shock
04/2017
1Bronchiolitis Obliterans Syndrome
11/2016
1Communicable Diseases (Infectious Diseases)
01/2016
1Pneumonia (Pneumonitis)
01/2016
1Insulin Resistance
02/2014
1Abdominal Obesity
02/2014
1Hepatic Encephalopathy
11/2012

Drug/Important Bio-Agent (IBA)

13Antiviral Agents (Antivirals)IBA
01/2022 - 08/2000
10AntigensIBA
04/2017 - 01/2004
8LipidsIBA
02/2014 - 02/2006
8Antifungal AgentsIBA
04/2011 - 03/2004
7Amphotericin B (Amphotericin)FDA LinkGeneric
02/2010 - 10/2005
7Immunosuppressive Agents (Immunosuppressants)IBA
11/2008 - 07/2002
6ValganciclovirFDA Link
01/2022 - 01/2005
6Calcineurin InhibitorsIBA
01/2015 - 08/2005
5Voriconazole (Vfend)FDA LinkGeneric
04/2011 - 02/2006
4Tacrolimus (Prograf)FDA LinkGeneric
03/2014 - 08/2005
4Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
03/2011 - 03/2009
3Pharmaceutical PreparationsIBA
01/2020 - 02/2010
3Biomarkers (Surrogate Marker)IBA
12/2011 - 02/2011
3Fluconazole (Zonal)FDA LinkGeneric
04/2010 - 10/2005
3Caspofungin (Cancidas)FDA Link
09/2009 - 02/2006
3galactomannanIBA
05/2007 - 01/2004
3Ganciclovir (Cytovene)FDA LinkGeneric
01/2005 - 04/2002
2InflammasomesIBA
01/2017 - 02/2011
2Rifampin (Rifampicin)FDA LinkGeneric
03/2014 - 05/2013
2Biological ProductsIBA
03/2011 - 09/2009
2CholesterolIBA
10/2010 - 05/2010
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2010 - 04/2002
2CytokinesIBA
11/2008 - 08/2006
2IronIBA
09/2008 - 12/2007
2Immunoglobulins (Immunoglobulin)IBA
06/2007 - 07/2006
2EnzymesIBA
05/2007 - 01/2004
1Calcium Carbonate (Limestone)FDA Link
03/2021
1DNA-Directed DNA Polymerase (Polymerases, DNA)IBA
01/2021
1Anti-Bacterial Agents (Antibiotics)IBA
10/2020
1letermovirIBA
01/2020
1cyclo(Arg-Pro) (CI 4)IBA
01/2020
1maribavirIBA
01/2020
1Rituximab (Mabthera)FDA Link
12/2017
1PesticidesIBA
01/2017
1Proteins (Proteins, Gene)FDA Link
01/2017
1Busulfan (Busulfex)FDA Link
11/2016
1Tuberculin (PPD)IBA
11/2016
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2016
1Adrenal Cortex Hormones (Corticosteroids)IBA
11/2016
1Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
11/2016
1IA 3 (IA-3)IBA
12/2015
1Glucose (Dextrose)FDA LinkGeneric
02/2014
1Telmisartan (Micardis)FDA Link
02/2014
1AdiponectinIBA
02/2014
1Angiotensin IIIBA
02/2014
1liposomal amphotericin BFDA Link
09/2013
1Micafungin (FK463)FDA Link
09/2013
1Rifaximin (L 105)FDA Link
11/2012

Therapy/Procedure

42Liver Transplantation
11/2021 - 04/2001
25Therapeutics
01/2021 - 08/2000
21Transplantation
11/2021 - 01/2002
4Organ Transplantation
01/2020 - 03/2003
4Lung Transplantation
03/2003 - 03/2002
3Drug Therapy (Chemotherapy)
01/2009 - 08/2006
2Artificial Respiration (Mechanical Ventilation)
04/2017 - 01/2009
2Duration of Therapy
10/2005 - 11/2003
1Self-Testing
01/2020
1Cell Transplantation
01/2020
1Homologous Transplantation
11/2016